Australia markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1200+0.0500 (+2.42%)
At close: 04:00PM EDT
2.0900 -0.03 (-1.42%)
After hours: 05:16PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
136,361
127,044
107,672
86,346
88,638
Cost of revenue
47,055
65,105
54,874
46,021
36,189
Gross profit
89,306
61,939
52,798
40,325
52,449
Operating expenses
Research development
42,891
55,897
107,506
130,821
174,533
Selling general and administrative
92,807
116,657
119,950
127,332
106,079
Total operating expenses
135,698
172,554
227,456
258,153
280,612
Operating income or loss
-46,392
-110,615
-174,658
-217,828
-228,163
Interest expense
-
3,868
2,474
2,410
1,901
Total other income/expenses net
-1,231
560
-6,530
-878
-847
Income before tax
-48,127
-110,559
-182,024
-220,683
-227,278
Income from continuing operations
-48,127
-110,559
-182,024
-220,683
-227,278
Net income
-48,127
-110,559
-182,024
-220,683
-227,278
Net income available to common shareholders
-48,127
-110,559
-182,024
-220,683
-227,278
Basic EPS
-0.88
-0.80
-1.67
-2.24
-2.50
Diluted EPS
-0.88
-0.80
-1.67
-2.24
-2.50
Basic average shares
130,094
138,135
108,996
98,471
90,774
Diluted average shares
130,094
138,135
108,996
98,471
90,774